Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: An immunohistochemical study

Histopathology

Volumn 32, Issue 3, 1998, Pages 232-238

  Kasami, M ^a   Olson, S J ^a   Simpson, J F ^a   Page, D L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

catenin; Adenoid cystic carcinoma; Breast neoplasms; Cytokeratin; E cadherin; Fodrin; Human; Immunohistochemistry; Polarity; Vimentin

Indexed keywords

ALPHA ACTIN; BETA CATENIN; CELL MARKER; CYTOKERATIN; FODRIN; UVOMORULIN; VIMENTIN;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BASOLATERAL MEMBRANE; BREAST CARCINOMA; CELL DIFFERENTIATION; CELL POLARITY; CELL POPULATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, ADENOID CYSTIC; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL POLARITY; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LAMININ; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; TRANS-ACTIVATORS; VIMENTIN;

FELIS CATUS;

EID: 0031911348     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00383.x     Document Type: Article

References (31)

1. Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. Cancer 1992: 69; 2631-2639.
2. Anthony PP, James PD. Adenoid cystic carcinoma of the breast: prevalence. diagnostic criteria, and histogenesis. J. Clin. Pathol. 1975: 28; 647-655.
3. Wells CA, Nicoll S, Ferguson DJP. Adenoid cystic carcinoma of the breast: a case with axillary lymph node metastasis. Histopathology 1986: 10; 415-424.
4. Cheng J, Liu AR, Liu ZH. A clinicopathological study of 225 cases of adenoid cystic carcinoma of salivary glands. Clin. J. Stomatol. 1985: 20; 15-18.
5. Eichhorn JH, Scully RE. Adenoid cystic and basaloid carcinomas of the ovary: evidence for a surface epithelial lineage. A report of 12 cases. Mod. Pathol. 1995: 8; 731-739.
6. Yamada K. Immunohistochemical expression of E-cadherin in salivary glands and their tumors. Acta Histochem. Cytochem. 1996: 29; 305-310.
7. Osborn M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab. Invest. 1983: 48; 372-394.
8. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: pattern of expression in normal epithelia, tumors and cultured cells. Cell 1982: 31; 11-24.
9. Böcker W, Bier B, Freytag G et al. An immunohistochemical study of the breast and luminal keratin, alpha-smooth muscle actin, vimentin. collagen IV and laminin. Virchows Arch. [A] 1992: 421; 315-322.
10. Azzopardi JG. Problems in Breast Pathology. Philadelphia: W.B. Saunders Ltd. 1979: 355-339.
11. Koss LG, Brannan CD, Ashikari R. Histologic and ultrastructual features of adenoid cystic carcinoma of the breast. Cancer 1970: 6; 1271-1279.
12. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. Am. J. Surg. Pathol. 1986: 10; 568-576.
13. Behan A, Ratschek M, Zatloukal K, Shmid C, Denk H. Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy. Virchows Arch. [A] 1992: 421; 209-213.
14. Haruna Y, Saito K, Spaulding S, Nelesnik MA, Gerber MA. Identification of bipotential progenitor cells in human liver development. Hepatology 1996: 23; 476-481.
15. Miettinen M, Franssila K, Lehto V, Paasivuo R, Vietanen I. Expression of intermediate filament proteins in thyroid gland and thyroid tumors. Lab. Invest. 1984: 50; 262-270.
16. Upton MP, Hirohashi S, Tome Y et al. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am. J. Surg. Pathol. 1986: 10; 560-567.
17. Utsunomiya T, Yao T, Masuda K, Tsuneyoshi M. Vimentin-positive adenocarcinoma of the stomach: co-expression of vimentin and cytokeratin. Histopathology 1996: 29; 507-516.
18. Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am. J. Pathol. 1990: 136; 219-227.
19. Holck S, Pedersen L, Schiodt T, Zedeler K, Mouridsen H. Vimentin expression in 98 breast cancers with medullary features and its prognostic significance. Virchows Arch. [A] 1993: 422; 475-479.
20. Roskelley CD, Desprez PY, Bissell MJ. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA 1994: 91; 12378-12382.
21. Lochter A, Bissell MJ. Involvement of extracellular matrix constituents in breast cancer. Cancer Biol. 1995: 6; 165-173.
22. McNeill H, Ozawa M, Kemler R, Nelson WJ. Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity. Cell 1990: 62; 309-316.
23. Molitoris BA, Nelson J. Alteration in the establishment and maintenance of epithelial cell polarity as a basis for disease processes. J. Clin. Invest. 1990: 85; 3-9.
24. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junction and the prevention of invasiveness. Biochem. Biophys. Acta 1994: 1198; 11-26.
25. Streuli CH, Schmidhauser C, Bailey N et al. Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 1995: 129; 591-603.
26. Younes M, Harris AS, Morrow JS. Fodrin as a differentiation markers: Redistributions in colonic neoplasia. Am. J. Pathol. 1989: 135; 1197-1212.
27. Glukhova M, Koteliansky V, Sastre X, Thiery J-P. Adhesion systems in normal breast and in invasive breast carcinoma. Am. J. Pathol. 1995: 146; 706-716.
28. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T. Expression of β-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996: 29; 139-146.
29. Simpson JF, Page DL. Altered expression of a structural protein (fodrin) within epithelial proliferative disease of the breast. Am. J. Pathol. 1992: 141; 285-289.
30. Weaver YM, Petersen OW, Wang F et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 1997: 137; 231-245.
31. Kleer CG, Oberman HA. Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity. Mod. Pathol. 1997: 10; 21A.